Cargando…
Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression
Cancer-testis (CT) antigens, rarely in normal tissues except testis, are expressed in many tumor types. In recent years, DDX43 has been shown to be expressed in several malignancies. However, the role of DDX43 during tumorigenesis is not well established. In the present study, we explored the functi...
Autores principales: | Lin, J., Ma, J.-C., Yang, J., Yin, J.-Y., Chen, X.-X., Guo, H., Wen, X.-M., Zhang, T.-J., Qian, W., Qian, J., Deng, Z.-Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931985/ https://www.ncbi.nlm.nih.gov/pubmed/29449695 http://dx.doi.org/10.1038/s41388-018-0146-y |
Ejemplares similares
-
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
por: Wang, Zhongrui, et al.
Publicado: (2023) -
MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1
por: Lu, Xiurong, et al.
Publicado: (2021) -
Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression
por: Zhao, X, et al.
Publicado: (2017) -
The KH domain facilitates the substrate specificity and unwinding processivity of DDX43 helicase
por: Yadav, Manisha, et al.
Publicado: (2020) -
miR-186 induces tetraploidy in arsenic exposed human keratinocytes
por: Ferragut Cardoso, Ana P., et al.
Publicado: (2023)